Rheumatological Conditions

Diagnostic Approach

The American College of Rheumatology suggests considering HLA-B27 testing if symptoms suggest reactive arthritis or spinal involvement 1
Joint fluid analysis is recommended if septic or crystal arthritis is suspected, according to the European Society for Medical Oncology 2
Plain radiographs are used to exclude metastases and evaluate joint damage (erosions), as recommended by the American College of Radiology and the European Society for Medical Oncology 1, 2
The American College of Rheumatology recommends using ultrasound or MRI if clinical suspicion warrants, especially for persistent arthritis unresponsive to treatment, suspicion of differential diagnoses, or detection of subclinical inflammation 1
A complete autoimmune panel, including antinuclear antibodies (ANA), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP), is recommended for diagnosis, as suggested by the American College of Rheumatology 3
Essential laboratory tests for RA diagnosis include ESR, CRP, RF, and ACPA 4

The following serological markers are used for RA diagnosis:

Test	Sensitivity	Specificity	Comments
Anti-CCP	67-78.5%	95-98%	Highest specificity, included in 2010 ACR/EULAR criteria
RF	69-84%	78-85%	Higher sensitivity but lower specificity
ANA	Lower	Lower	Not specific for RA, more relevant for other autoimmune conditions
Anti-Smith	Not indicated	Not indicated	More specific for SLE, not RA

5, 6, 3

The presence of positive autoantibodies (RF or anti-CCP), persistent joint symptoms with elevated inflammatory markers, joint swelling (synovitis), and symptoms persisting beyond 6 weeks are indicative of a potential rheumatological condition, according to the American College of Rheumatology 1, 2
A score of ≥6 indicates definite Rheumatoid Arthritis (RA) 7
The combination of body aches, joint pain, and elevated inflammatory markers is consistent with Polymyalgia Rheumatica (PMR) or Rheumatoid Arthritis (RA), according to the European League Against Rheumatism and the American College of Rheumatology, with a recommended workup including complete autoimmune panel and imaging studies 8, 3

Methotrexate is the preferred first-line disease-modifying antirheumatic drug (DMARD) for RA, with a dosage of 7.5-15mg weekly, escalating to 20-25mg, and subcutaneous administration is preferred over oral due to better bioavailability 9, 10, 11, 7, 6, 12
Biologic drugs are indicated in patients with peripheral arthritis and inadequate response to at least one DMARD, with options including tumor necrosis factor (TNF) inhibitors, abatacept, and tocilizumab 9, 13, 10
Janus kinase inhibitors (JAKi) should be considered in patients with peripheral arthritis and inadequate response to at least one DMARD, or when a DMARD is not appropriate, with consideration of safety concerns 9, 13
Nonsteroidal anti-inflammatory drugs (NSAIDs) and local injections of glucocorticoids are recommended as adjuvant therapy to alleviate musculoskeletal symptoms 9, 13, 6, 3
The European League Against Rheumatism recommends starting with prednisone 10-20 mg daily, with monitoring for response within 1-2 weeks, and maintaining dose for 3-4 weeks then beginning slow taper if symptoms improve 8, 1

Disease activity should be monitored monthly for patients with high/moderate disease activity, and less frequently (every 6 months) for patients in sustained low disease activity or remission, as recommended by the American College of Rheumatology 14
Target remission (SDAI ≤3.3) or at minimum low disease activity (SDAI ≤11) in patients with rheumatoid arthritis, and adjust therapy if no improvement is seen by 3 months or target is not reached by 6 months 15
If sustained remission ≥1 year, consider de-escalation of therapy (≤1 trial), and in patients managed with treat-to-target strategy, therapy can be tapered successfully in some cases, with sustained drug-free remission possible in 15-25% 7
Cardiovascular risk should be assessed, as RA is associated with a 50% increase in cardiovascular morbidity and mortality, as recommended by the European Society of Cardiology 16
Lipid profile testing and assessment for traditional cardiovascular risk factors, such as hypertension, diabetes, and smoking, are recommended 16
Screening for depression and other psychosocial factors, as well as assessing for chronic kidney disease, hypothyroidism, and periodontitis, are also recommended 16
Regular urinalysis for proteinuria should be performed to monitor for development of amyloidosis 17

Septic arthritis should be treated with immediate orthopedic consultation, joint drainage, and empiric broad-spectrum antibiotics pending culture results, with hospitalization for intravenous antibiotics 3
Acute attacks of gout or pseudogout can be treated with NSAIDs, colchicine, or intra-articular corticosteroid injections, with urate-lowering therapy after acute attack resolves for gout 3
Ultrasound or MRI of affected joints is recommended if there is persistent arthritis, as suggested by the American College of Rheumatology 3